课题基金 / 基金详情

Diabetes Research Training Program

Diabetes Research Training Program
糖尿病研究培训计划
批准号:
9280334
负责人:
E Dale Abel
金额:
$39.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30

项目摘要

项目成果

E Dale Abel的其他基金

相似基金

相关文献

中文摘要
翻译
1个项目摘要/摘要 2. 3迫切需要设计更好的方法来预防、治疗并最终逆转糖尿病,这是 4需要不断培训熟练的调查员队伍。新的糖尿病研究培训计划位于 爱荷华大学的定位是指导和启动下一代调查人员,他们将 6这一迫切需要,并将他们的科学努力集中在糖尿病上。我们正在为6名博士后寻求支持 7个位置。医生和博士科学家都将接受培训,大多数人将被任命参加为期两年的计划 8年了。该州没有其他糖尿病研究培训机会。该计划是建立在 9爱荷华大学兄弟会老鹰糖尿病研究中心(FOEDRC)的众多优势, 10正在推动旨在进一步了解糖尿病及其病理生理学的创新策略 11并发症和制定新的预防和治疗策略。基础和临床科学培训 12调查将得到糖尿病、新陈代谢、拨款撰写和研究伦理等核心课程的支持。 13名参与临床和/或转化性糖尿病研究的实习生将注册并完成科学硕士学位 转化型生物医学专业14人。学员将接受量身定制的职业指导,以确保成功过渡到 15他们职业生涯的下一个阶段。该中心注入了整合的精神,并协同科学 将推动16项跨科学领域的合作。中提供的指导研究机会 17计划跨越非常广泛的模式生物的基础和机械研究,以 18项针对人类的翻译研究。该计划的导师由37名不同但互动的FOEDRC教师组成 19拥有强有力的糖尿病研究计划,稳定的外部资金,稳健的培训记录。它们的跨度为8 20个科室和9个临床科室。培训将利用与协作的现有协同效应 21个中心。FOEDRC的广泛影响力将确保招募优秀的受训人员。合格 22名内科科学家实习生将从内科科学家培训路径和盟军招募 23个儿科和内科临床团契培训项目。博士科学家实习生将被选中 24人来自国家人才库,招募到计划导师实验室。培训计划将通过 25 FOEDRC,并将由一个由2名联席首席调查员和4名联席首席调查员组成的执行委员会监督。 26名董事,他们都是经验丰富的调查人员,坚定不移地致力于指导学员。
英文摘要
1 PROJECT SUMMARY / ABSTRACT 2 3 There is a drastic need to devise better approaches to prevent, treat, and ultimately reverse diabetes, which 4 requires constant training of skilled cohorts of investigators. The new Diabetes Research Training Program at 5 the University of Iowa is positioned to mentor and launch the next generation of investigators who will address 6 this critical need and focus their scientific efforts on diabetes. We are seeking support for 6 postdoctoral 7 positions. Both physician and PhD scientists will be trained and most will be appointed to the program for 2 8 years. There exist no other diabetes research training opportunities in the state. The program is built on the 9 myriad strengths of the University of Iowa Fraternal Order of Eagles Diabetes Research Center (FOEDRC), 10 which is driving innovative strategies aimed at further understanding the pathophysiology of diabetes and its 11 complications and at devising novel preventative and curative strategies. Training in basic and clinical scientific 12 investigation will be backed by a core curriculum in diabetes, metabolism, grant writing, and research ethics. 13 Trainees involved in clinical and/or translational diabetes research will enroll and complete a Master of Science 14 in Translational Biomedicine. Trainees will receive tailored career mentoring to ensure a successful transition to 15 the next stage of their career. The Center is infused with an integrative spirit, and synergistic scientific 16 collaborations across scientific realms will be promoted. Mentored research opportunities available in the 17 Program span basic and mechanistic investigation across a very broad range of model organisms to 18 translational studies in humans. The Program mentors comprise 37 diverse but interactive FOEDRC faculty 19 with vigorous diabetes research programs, stable extramural funding, robust training records. They span 8 20 departments and 9 clinical divisions. Training will take advantage of existing synergies with collaborating 21 centers. Recruitment of outstanding trainees will be secured by the broad reach of the FOEDRC. Qualified 22 physician scientist trainees will be recruited from the Physician Scientist Training Pathway and from allied 23 clinical fellowship training programs in Pediatrics and Internal Medicine. PhD scientist trainees will be selected 24 from national pools recruited into Program mentors labs. The training program will be administered through the 25 FOEDRC, and will be overseen by an executive committee comprising 2 co-principal investigators and 4 co- 26 directors, all of whom are seasoned investigators with uncompromising commitment to mentoring trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes
  • 批准号:
    10570226
  • 项目类别:
  • 资助金额:
    $46.85万
  • 财政年份:
    2021
  • 负责人:
    E Dale Abel
  • 依托单位:
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes
  • 批准号:
    10393667
  • 项目类别:
  • 资助金额:
    $46.85万
  • 财政年份:
    2021
  • 负责人:
    E Dale Abel
  • 依托单位:
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation
  • 批准号:
    10026343
  • 项目类别:
  • 资助金额:
    $72.43万
  • 财政年份:
    2018
  • 负责人:
    E Dale Abel
  • 依托单位:
海外基金